Home| About us| My LA: login/register| For authors| For reviewers| Submit a paper
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


 Yes, sign up now
 Sign up for general news too

Privacy Statement
 
 
 

Clinical Medicine: Endocrinology and Diabetes

Synopsis: An open access, peer reviewed electronic journal that covers diabetes and endocrine disorders.


Indexing: 4 major databases. Pubmed indexing for NIH-funded research.

Processing time: Decision in 2 weeks for 90% of papers.

Visibility: Most popular article read 700+ times.

View factor
for journal
17383
 
 
 
 
 
 

About this journal

Clinical Medicine: Endocrinology and Diabetes

ISSN: 1178-1173

Aims and scope:

Clinical Medicine: Endocrinology and Diabetes is an international, open access, peer reviewed journal which considers manuscripts on diabetes and all other disorders of the endocrine system, in addition to related genetic, pathophysiological and epidemiological topics.

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

Indexing:

This journal is indexed by:

  • Google Scholar
  • CAS
  • Scopus
  • EMBase

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 

 
 
 


Chronic Haemolytic Anemia and Splenomegaly in a Patient with an Isolated Adrenocorticotropin Deficiency

Authors: Rania Abdel-Muneem Ahmed, Koji Murao, Hitomi Imachi, Noriko Kitanaka, Tomie Muraoka, Kensuke Matsumoto, Takamasa Nishiuchi, Yukiko Nishiuchi and Toshihiko Ishida
Publication Date: 01 Mar 2008
Clinical Medicine: Endocrinology and Diabetes 2008:1 7-11

Rania Abdel-Muneem Ahmed, Koji Murao, Hitomi Imachi, Noriko Kitanaka, Tomie Muraoka, Kensuke Matsumoto, Takamasa Nishiuchi, Yukiko Nishiuchi and Toshihiko Ishida

Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe Miki-CHO, Kita-gun, Kagawa, Japan.

Abstract

Herein we describe a case of a 56-years old patient presented with general malaise, anorexia and progressive weight loss for about 5years associated recently with diarrhoea and repeated syncopal attacks for 1month. On admission, he had splenomegaly and his laboratory studies showed macrocytic hyperchromic haemolytic anemia [Hb = 9.4g/dl] and a significant hyponatremia [Na+ = 111mmol/l]. Endocrinological evaluation revealed an isolated adrenocorticotropin deficiency (IAD) with a manifest hypoaldosteronism. On treatment with cortisone, both anemia and hyponatremia (but not splenomegaly) were markedly improved. Our case may represent an evidence for the pathogenesis of erythropoietic dysfunction in patients of adrenocortical insufficiency.

Categories: Endocrine disorders


Post comment




No comments yet...Be the first to comment.

Document tools

Download PDF
(340.18 KB)
Request Reprints

Sign up for free journal updates

How should we address you?
Your email address
 Yes, sign up now


Recently published in this journal

Racial Disparities on Glycemic Control and Lipid Profiles in Children with Type 1 Diabetes
- 09/Feb/2009

HbA1c is an Independent Determinant of Renal Vascular Resistance Estimated by Doppler Sonography in Non-Diabetic Hypertensive Patients
- 24/Nov/2008

The Switch Study: Switching from BHI 30 Novolet® to BIAsp 30 Flexpen®: ‘Clinical Observations from the Netherlands’. Treatment Satisfaction when Switching from BHI 30 NovoLet® to BIAsp 30 FlexPen®
- 31/Oct/2008

Adipocytokines as Influenced by Family History of Type 2 Diabetes and Smoking in Non-Diabetic Subjects
- 29/Apr/2008

Diabetes Mellitus as Dysfunction of Interactions Among all Organs: “Ominous Orchestra of Organs”
- 01/Mar/2008

Chronic Haemolytic Anemia and Splenomegaly in a Patient with an Isolated Adrenocorticotropin Deficiency
- 01/Mar/2008



Related journals...